Why you should attend

• Gain new insights on how to apply molecular interaction information to aid drug discovery and development
• Learn reliable methods to compare binding properties of antibody derivatives
• Use molecular interaction analyses to accelerate identification of high potential therapeutic antibody candidates
• Determine the latest emerging developments in label-free detection systems
• Compare PK assay formats and improve accuracy on drug measurement
• Assay development principles and technical approaches are revealed
• ADC technologies - ELISA PK assay considerations, compare in vivo vs. in vitro stability, mass spectrometric-based ADC strategies
• How does in vitro Fc functionality data relate to in vivo activity, efficacy, and safety?
• Fc effector functions - biology, strategies, challenges, and methodologies